Company Filing History:
Years Active: 2004
Title: Heribert Miklautz: Innovator in Radioactive Stents
Introduction
Heribert Miklautz is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical technology, particularly in the development of stents designed to prevent restenosis. His innovative work has led to the creation of a patented solution that enhances patient outcomes in cardiovascular procedures.
Latest Patents
Miklautz holds a patent for "Stents with a radioactive surface coating, processes for their production and their use for restenosis prophylaxis." This invention involves stents that are coated with a radioactive isotope, which plays a crucial role in preventing the recurrence of arterial blockages after treatment. The patent highlights both the unique characteristics of the stents and the processes involved in their production.
Career Highlights
Heribert Miklautz is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical and healthcare sector. His work at Schering has allowed him to focus on innovative solutions that address critical health challenges. His expertise in the field has positioned him as a key figure in the development of advanced medical devices.
Collaborations
Miklautz has collaborated with notable colleagues, including Ludger Dinkelborg and Friedhelm Blume. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately leading to groundbreaking advancements in medical technology.
Conclusion
Heribert Miklautz's contributions to the field of medical technology, particularly through his patented radioactive stents, demonstrate his commitment to improving patient care. His innovative spirit and collaborative efforts continue to influence the landscape of cardiovascular treatment.